follow_the_money

(Nasdaq: KPTI) Karyopharm tx "catching a falling knife"

Penjualan
NASDAQ:KPTI   Karyopharm Therapeutics Inc.
Recently FDA released data suggesting KPTI and myloma medicationi was too "Toxic" their MM chemo drug had SERIOUS toxicity AEs and even DEATH. Cohort of 123 pts ~86% had some sort of serious AE and ~24% dropped out because of this. to find out more about what happened and why SP dropped, see synopsis in the link below.

Synopsis of Data can be found here- opening bell 2/25/2018:
msmoneymoves.com/


NDA application: -// Failed*
www.fda.gov/download...mittee/UCM631806.pdf

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.